CARDIOVASCULAR
hamburger

Course Offerings for Heart Failure Fellows

This page outlines courses specifically designed for PGY7 and 8 Fellows working towards their Advanced Heart Failure or Cardiac Surgery certifications.

Course offerings for the current academic year will include technologies such as the CardioMEMS™ HF System, HeartMate 3™ LVAD, and the CentriMag™ Acute Circulatory Support System.

To express interest in registering for a course, reach out to your local Abbott representative or request information directly from our Academic Development team.

FEATURED UPCOMING COURSES AND EVENTS

Treatment of Acute to Chronic HF

Gain a fundamental understanding of how technology is used to provide the standard of care for heart failure (HF) patients. World-class faculty will share expert insights on both non-invasive and invasive care strategies and present a comprehensive review of evidence-based medicine to assess their cost effectiveness.

August 22-23, 2020
Washington, DC

Request Information



Pathways and Procedures for Late Stage HF

This educational program will address knowledge gaps related to heart failure management for advanced heart failure patients. At the end of the program, participants will have a greater understanding of how to optimize medical and device therapy for patients across the full spectrum of heart failure, integrating emerging technologies for remote monitoring and mechanical circulatory support.

March 6-7, 2021
Miami, FL

Request Information

Webinar Series for Fellows

We offer webinars for cardiovascular fellows throughout the year. Recordings of past webinars are also available.

INDICATIONS, SAFETY & WARNINGS

Rx Only

Brief Summary:

Prior to using these devices, please review the Instructions For Use for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use.

Indications:

The HeartMate​ 3​ Left Ventricular Assist System is indicated for providing short- and long-term mechanical circulatory support (e.g., as bridge to transplant or myocardial recovery, or destination therapy) in patients with advanced refractory left ventricular heart failure.

Contraindications:

The HeartMate 3 Left Ventricular Assist System is contraindicated for patients who cannot tolerate, or who are allergic to, anticoagulation therapy.

Adverse Events:

Adverse events that may be associated with the use of the HeartMate 3 Left Ventricular Assist System are: death, bleeding, cardiac arrhythmia, localized infection, right heart failure, respiratory failure, device malfunctions, driveline infection, renal dysfunction, sepsis, stroke, other neurological event (not stroke-related), hepatic dysfunction, psychiatric episode, venous thromboembolism, hypertension, arterial non-central nervous system (CNS) thromboembolism, pericardial fluid collection, pump pocket or pseudo pocket infection, myocardial infarction, wound dehiscence, hemolysis (not associated with suspected device thrombosis) or device thrombosis.

MAT-1900228 v3.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

True
accessibility
© 2019 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.